How high deductible health plans and COVID-19 affect access to alcohol use disorder treatment
Impact of high deductible health plans and COVID-19 on alcohol use disorder treatment access, outcomes, and disparities
['FUNDING_R01'] · DUKE UNIVERSITY · NIH-10907544
This study looks at how high deductible health plans and the COVID-19 pandemic affect adults' ability to get treatment for alcohol use disorder, especially for those who may already face challenges, and it aims to find ways to make care more accessible for everyone.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DUKE UNIVERSITY (nih funded) |
| Locations | 1 site (DURHAM, UNITED STATES) |
| Trial ID | NIH-10907544 on ClinicalTrials.gov |
What this research studies
This research investigates how high deductible health plans and the COVID-19 pandemic impact access to treatment for alcohol use disorder. It aims to understand the barriers that prevent adults, particularly those from disadvantaged backgrounds, from receiving necessary care. The study will analyze treatment access and outcomes before and after significant changes in health plan policies and the pandemic's onset. By examining these factors, the research seeks to identify disparities in treatment access and propose solutions to improve care.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults aged 21 and older who are experiencing alcohol use disorder and may be affected by high deductible health plans or the COVID-19 pandemic.
Not a fit: Patients who do not have alcohol use disorder or those who are not impacted by high deductible health plans or COVID-19 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to alcohol use disorder treatment for millions of affected adults.
How similar studies have performed: Previous research has shown that societal factors significantly impact access to healthcare, suggesting that this study's approach could yield valuable insights.
Where this research is happening
DURHAM, UNITED STATES
- DUKE UNIVERSITY — DURHAM, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WHARAM, JAMES FRANKLIN — DUKE UNIVERSITY
- Study coordinator: WHARAM, JAMES FRANKLIN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.